Verge Genomics' ALS Drug Fails Amid Shift to Partner Model
TL;DR
Verge Genomics' only clinical-stage ALS drug has failed, prompting the company to shift its focus to a partnership model for its AI-driven discovery platform.
Topics:healthbusiness#ai-driven-discovery#als-drug#biotech#business#partnership-model#verge-genomics
Want the full story? Read the original reporting
Read on Endpoints News